These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16440454)

  • 1. Medicare Part D: decision, decisions, decisions. Medicare prescription drug coverage should save many people some money, but it puts a new burden on beneficiaries to be smart shoppers.
    Harv Health Lett; 2005 Dec; 31(2):4-5. PubMed ID: 16440454
    [No Abstract]   [Full Text] [Related]  

  • 2. Access to Medicare Part D gap coverage more scarce in 2007.
    Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare Part D: who wins, who loses?
    Am Fam Physician; 2006 Feb; 73(3):401. PubMed ID: 16477886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Out-of-pocket prescription costs a continuing burden under Medicare Part D.
    Am Fam Physician; 2006 Feb; 73(3):402. PubMed ID: 16477887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug expenditures, financial burden and health plan satisfaction among medicare beneficiaries.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(5):453-4, 455-6. PubMed ID: 14613446
    [No Abstract]   [Full Text] [Related]  

  • 6. Mind the gap: Medicare Part D's coverage gaps may affect patient adherence.
    Am Fam Physician; 2006 Feb; 73(3):404. PubMed ID: 16477888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare Part D: practical and policy implications for family physicians.
    Mallya G; Bazemore A
    Am Fam Physician; 2006 Feb; 73(3):395-6. PubMed ID: 16477884
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights of the Medicare Prescription Drug Act.
    Conomikes GS
    J Okla State Med Assoc; 2005 Oct; 98(10):492-3. PubMed ID: 16296207
    [No Abstract]   [Full Text] [Related]  

  • 9. Private, individual drug coverage in the current Medicare market.
    Boccuti C; Moon M
    Policy Brief Commonw Fund; 2003 Oct; (679):1-10. PubMed ID: 14562796
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing the gap in medicare Part D's prescription coverage. Interview by Cheryl Thompson.
    Durley SF
    Am J Health Syst Pharm; 2006 Dec; 63(23):2319, 2323, 2326. PubMed ID: 17106004
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription-drug coverage for medicare beneficiaries.
    Iglehart JK
    N Engl J Med; 2003 Sep; 349(10):923-5. PubMed ID: 12954738
    [No Abstract]   [Full Text] [Related]  

  • 12. Medicare and prescription drugs.
    Iglehart JK
    N Engl J Med; 2001 Mar; 344(13):1010-5. PubMed ID: 11274630
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of supplemental medical and prescription drug coverage on health care spending for Medicare beneficiaries with cancer.
    Erten MZ; Davidoff AJ; Zuckerman IH; Shaffer T; Dougherty JS; Ke X; Stuart B
    Value Health; 2014; 17(1):15-21. PubMed ID: 24438713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sustainable future?: the role of premium subsidies in Medicare prescription drug plans.
    Demchak C
    Find Brief; 2007 Jan; 10(2):1-6. PubMed ID: 17302011
    [No Abstract]   [Full Text] [Related]  

  • 18. Caught in between: prescription drug coverage of Medicare beneficiaries near poverty.
    Shea DG; Stuart BC; Briesacher B
    Issue Brief (Commonw Fund); 2003 Aug; (669):1-8. PubMed ID: 12926411
    [No Abstract]   [Full Text] [Related]  

  • 19. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The road all-too-well traveled: a year of Medicare Part D and what we have learned so far.
    Hays R; Paykin C
    Prog Transplant; 2007 Mar; 17(1):68-9. PubMed ID: 17484249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.